| Parameter |
Tenofovir Monotherapy (TM, Gr. 1, n=30) |
Peg-IFN plus Tenofovir Sequential Therapy (SQT, Gr. 2, n=28) |
P Values |
| Age (years) mean ± SD |
35.4± 15 |
29.9 ± 11.9 |
P=0.13 (NS) |
| Sex (M:F) |
22:08 |
24:04:00 |
P=0.24 ( NS) |
| Median Serum bilirubin (mg/dl; range) |
0.7 (0.5-1.2) |
0.75 (0.4-1.5) |
NS |
| Median Albumin (g/dl ; range) |
4.3 (0.8-4.7) |
4.35 (3.7-5) |
NS |
| Median ALT (IU/L; range) |
60.5 (45-230) |
62.5 (45-205) |
NS |
| HBV DNA (mean ± SD; log10 copies/ml) |
6.26 ± 1.25 |
6.61± 1.16 |
P=0.33 (NS ) |
|
